Murepavadin (TFA), a 14-amino-acid cyclic peptide, is a highly potent, specific antibiotic for the treatment of bacterial infections caused by Pseudomonas aeruginosa. Murepavadin (TFA) targets the lipopolysaccharide transport portin D .
Murepavadin TFA is a synthetic peptide antibiotic belonging to the class of peptidomimetics, specifically engineered to target Gram-negative bacterial pathogens. Characterized by its β-hairpin structure, this compound exhibits high specificity for the outer membrane protein LptD in Pseudomonas aeruginosa, making it a valuable research tool for studies on bacterial membrane integrity and antibiotic resistance mechanisms. Its unique mode of action, which involves disruption of lipopolysaccharide transport, distinguishes it from traditional antibiotics and positions it at the forefront of next-generation antimicrobial research.
Antimicrobial mechanism studies: Murepavadin TFA serves as a critical probe in elucidating the molecular mechanisms underlying selective antibacterial activity against Pseudomonas species. Researchers utilize it to dissect the interactions between peptidomimetic antibiotics and the outer membrane of Gram-negative bacteria, particularly focusing on the inhibition of LptD-mediated lipopolysaccharide assembly. These studies provide insights into the structure-activity relationships that govern peptide-based antimicrobial efficacy and inform the rational design of novel agents with improved selectivity and potency.
Resistance profiling and surveillance: The compound is widely employed in laboratory investigations aimed at characterizing the development and transmission of resistance in Pseudomonas aeruginosa. By subjecting bacterial populations to escalating concentrations of murepavadin analogues, scientists can monitor adaptive mutations and efflux mechanisms that contribute to reduced susceptibility. Such research is vital for tracking emerging resistance patterns and for developing diagnostic tools to detect resistance determinants in clinical and environmental isolates.
Membrane protein interaction assays: Due to its high affinity for LptD, murepavadin analogues are frequently used in biochemical and biophysical assays to study the structure, function, and dynamics of bacterial outer membrane proteins. Techniques such as surface plasmon resonance, isothermal titration calorimetry, and cross-linking experiments leverage the peptide's specificity to map interaction sites and elucidate conformational changes upon ligand binding. These applications advance the understanding of membrane protein biology and support the identification of new antibacterial targets.
Peptide antibiotic development: Murepavadin TFA acts as a reference scaffold in the development and optimization of next-generation peptide antibiotics. Medicinal chemists employ it as a benchmark for structure-guided modifications, aiming to enhance antibacterial activity, stability, and pharmacokinetic properties. Comparative studies with novel analogues facilitate the identification of critical pharmacophores and inform strategies for overcoming common challenges in peptide drug development, such as proteolytic degradation and membrane permeability.
Analytical and quality control applications: The compound is also utilized as a standard in analytical method development, including high-performance liquid chromatography (HPLC) and mass spectrometry protocols. Its well-characterized physicochemical properties make it suitable for validating assay sensitivity, specificity, and reproducibility in the quantification of peptide antibiotics. These analytical applications are essential for ensuring the reliability of research data and for supporting the quality assurance of peptide-based research reagents.
2. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate
3. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
4. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes
5. Emu oil in combination with other active ingredients for treating skin imperfections
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More